Precision Oncology News 10.22.19 Q&A: The Parker Institute’s Theresa LaVallee on the Path Forward for Precision Immuno-Oncology Read
TechCrunch 10.17.19 ArsenalBio emerges from stealth with $85 million and a dream team to fight cancer Read
San Francisco Business Times 10.17.19 Big money, tech, science back startup’s ambitious cell therapy play Read
Chemical & Engineering News 10.17.19 Parker Institute spin-off launches to make CRISPR-edited cell therapies Read
TIME 10.17.19 42nd U.S. President Bill Clinton to Join the TIME 100 Health Summit in New York, NY on October 17 Read
Endpoints News 10.17.19 Sean Parker helps create a CRISPRed cell therapy 2.0 play — and he’s got a high-profile set of leaders on the team Read